Theory and Therapy: On the Conceptual Structure of Models in Medical Research

Three models for the relationship between scientific research and practical intervention (as in technology development or medical therapy) are presented. The cascade model proceeds on the assumption that the control of natural processes requires the disentangling of their underlying causal relations. Emergentism claims that intervention needs to take subtle features of experience into account whose diversity and wealth transcend the grip of fundamental principles. Practical challenges need to be addressed by jettisoning the principles and by turning to the particulars of experience instead. The interactive view grants that general theory fails to capture the phenomena to a degree necessary to direct targeted intervention and claims that the empirical details only serve to complete and correct a theory-based conceptual framework. Studying cases from cancer research buttresses the interactive view. A theoretical framework for understanding the disease is of critical importance for devising treatment options. But these options are only vaguely outlined and need to be spelled out by drawing on the particulars of experience.

[1]  René Descartes,et al.  Discours de la Methode , 2013 .

[2]  J. Nam,et al.  Chronic inflammation and cancer in various organ systems , 2004 .

[3]  M. Carrier Theories for Use: On the Bearing of Basic Science on Practical Problems , 2009 .

[4]  N. Cartwright FUNDAMENTALISM vs THE PATCHWORK OF LAWS , 1994 .

[5]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[6]  Margaret Morrison,et al.  Models as Mediators: Models as autonomous agents , 1999 .

[7]  Michael J Thun,et al.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. , 2002, Journal of the National Cancer Institute.

[8]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[9]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[10]  G. Giannini,et al.  BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers. , 2006, Critical reviews in oncology/hematology.

[11]  F. Rösl,et al.  HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F–p73 pathway , 2004, Oncogene.

[12]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[13]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[14]  Nancy Cartwright Models: The Blueprints for Laws , 1997, Philosophy of Science.

[15]  Eric Winsberg,et al.  Simulated Experiments: Methodology for a Virtual World , 2003, Philosophy of Science.

[16]  Matthias Adam,et al.  Integrating research and development: the emergence of rational drug design in the pharmaceutical industry. , 2005, Studies in history and philosophy of biological and biomedical sciences.

[17]  Margaret Morrison,et al.  Models as Mediators , 1999 .

[18]  Nathan Rosenberg,et al.  Critical issues in science policy research , 1991 .

[19]  P. Vielh,et al.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.

[20]  A. Lozano,et al.  New movement in Parkinson's. , 2005, Scientific American.

[21]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[22]  D. E. Stokes Pasteur's Quadrant: Basic Science and Technological Innovation , 1997 .

[23]  J. Terdiman,et al.  Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies , 2005, The American Journal of Gastroenterology.

[24]  Miklós Rédei,et al.  EPSA Philosophical Issues in the Sciences · Launch of the European Philosophy of Science Association , 2009 .

[25]  Rajnish A. Gupta,et al.  Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 , 2001, Nature Reviews Cancer.

[26]  Wojciech Makalowski,et al.  Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features , 1999, Oncogene.

[27]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[28]  M. Carrier,et al.  How to serve the customer and still be truthful: methodological characteristics of applied research , 2006 .

[29]  Lisa Jardine,et al.  The New Organon , 2008 .

[30]  Syed Mohsin,et al.  Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer , 2003, The Lancet.

[31]  B. Godin The Linear Model of Innovation , 2006 .

[32]  Rens Bod,et al.  Towards a General Model of Applying Science , 2006 .

[33]  M. Lotze Inflammation, necrosis, and cancer , 2004 .

[34]  H. Leufkens,et al.  5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study , 2005, Gut.

[35]  Nancy Cartwright How theories relate : Takeovers or partnerships ? , 1998 .

[36]  Martin Carrier Knowledge Gain and Practical Use: Models in Pure and Applied Research , 2004 .

[37]  F. Rösl,et al.  The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. , 2002, Cancer letters.

[38]  Ying Liu,et al.  Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[39]  N. Cartwright How the laws of physics lie , 1984 .

[40]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[41]  M. Lotze,et al.  Cancer as a chronic inflammatory disease: role of immunotherapy , 2004 .